Entries by Scott Graves

SHEPHERD THERAPEUTICS TO FOCUS ON RARE CANCER CURES

Rare Cancer Patient Founds Biopharma Company To Treat Fellow Rare Cancer Patients

CAMBRIDGE, MA— November 24, 2016 — David Hysong is fighting for his life and using his story to save the lives of others. After being diagnosed with Adenoid Cystic Carcinoma (ACC), a rare cancer for which there is no cure or approved therapy, David reached out to former Genzyme senior vice president Gene Williams. Together they founded the rare cancer-focused biopharma company, SHEPHERD Therapeutics, on January 1, 2016.